Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Restrictions on the use of new lung cancer drug

Dec. 30, 2002

Xcytrin enters pivotal trial for treatment of brain metastases in NSCLC patients

Dec. 30, 2002

Epothilone B effective and well tolerated in advanced breast cancer

Dec. 30, 2002

Clinical results reported for lonafarnib in hematological malignancies

Dec. 30, 2002

Efficacy and safety of tipifarnib in leukemia and other hematological disorders

Dec. 30, 2002

Prinomastat monotherapy in low-risk myelodysplastic syndrome

Dec. 30, 2002

New data on the HDAC inhibitor MS-275 in leukemia

Dec. 30, 2002

Decalactones of fungal origin reported to exhibit antitumor and antiinfective activity

Dec. 27, 2002

CP-461 well tolerated in a phase I trial in patients with advanced cancer

Dec. 27, 2002

Arzoxifene and LG-100268 effective alone and in combination in a rat breast cancer model

Dec. 27, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...